INTICA Biomedical

About:

INTICA Biomedical develops a combined product that consists of targeted therapy and companion diagnostics for triple negative breast cancer.

Website: http://inticabio.com

Description:

INTICA Biomedical, Inc. develops a combination product consisting of Targeted Therapy & Companion Diagnostic for Triple Negative Breast Cancer (TNBC). The novel drug target DEspR and its associated pathway represent true breakthrough discoveries. The NCI and the Susan G Komen Foundation are actively supporting the company's development program in TNBC.